Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Letter from the Editor #682:

This weekend finds all of us at the ADA meeting in Chicago and we have some early releases on some of the findings. The great thing about the Scientific Sessions is that researchers of new drugs, techniques and methods of diabetes care put all...


Editor's Desk, DCMS #141

We are moving closer to the full bore effect of the Affordable Care Act and although there are many opinions as to how good or bad the idea is, it has increased healthcare coverage for many Americans. Part of the program's positive ideas includes...


Letter from the Editor #681

This week I was talking to a group of physician interns about food choices for diabetes and was trying to explain the value of a low carbohydrate program. During the discussion one of the students interrupted to advise the group that eating less...



Editor's Desk, DCMS #140

I just finished a class this morning with seven patients in an endocrinologist's office. They were seven of the most diverse patients I have ever had in a class; two patients on orals, an oral and basal insulin patient, a type 2 who was dependent...


Letter from the Editor, #680: Upsides and Downsides of ACO's

We have brought you a lot of information on the emergence of Accountable Care Organizations (ACOs) as a new model...


Editor's Note, DCMS #139

Jeremy Hodson Pettus, MD, and Steven Edelman, MD are back this week to help you understand adjunctive therapies that you can use with insulin patients to improve control of A1c's, while improving weight loss success.


Letter from the Editor #679: Sheri Colberg's New Book

Sheri R. Colberg, PhD, FACSM has been writing for us for the past seven years and she is our go-to guru when it comes to anything that has to do with diabetes and physical activity. We are proud to announce that her new...


Editor's Note, DCMS #138

This week in our Homerun Slides we get back to working with medications to focus on the core defects of diabetes and how selecting the right...


Letter from the Editor #678

We are at a point with oral medications for diabetes where there are new drug approvals in recently approved classes, new drug classes where the first in class is approved, as well as late trial research moving quickly for...


Editor's Note, DCMS #137

I just finished up a two day advisory board meeting for an insulin manufacturer. We looked at some new products and studies as well as new ideas about diabetes care. Part of our discussion had to do with the increased use of EMRs (electronic...


Letter from the Editor, #677

This week I happened to run into a physician friend I had not seen for a while. While we were chatting, I noticed that he must have gotten at least six pages from his answering service. Each time he had to call in and listen to the operator...


Letter from the Editor, SGLT-2 Inhibitors, Special Edition #2

Last month, in our first issue of these special edition newsletters we gave you the tools to become an expert on SGLT2-I therapy. In our second edition we want to...


Editor's Desk, DCMS #136

We often talk about the value of controlling lipids and glucose and their relation to patient health. If patients would only do what we tell them then the results would be good and our jobs would be easier. With the recent changes in healthcare,...


Letter from the Editor #676

This past week we had our PharmD candidate, Lauren Self, scour the information from the AACE meeting in Phoenix, in order to prepare the best articles for you to review. The new AACE guidelines that Dr. Alan...


DCMS #135

Have you ever heard of 1,5-Anhydroglucitol (1,5-AG)? If not get ready to learn in this week's Homerun Slides why testing for this compound will give...


Letter from the Editor, #675

Things are in full swing at AACE this weekend and we will be bringing you the most important and usable information in next week's newsletter.    One of the most talked-about insulin-delivery products is the


DCMS #134

Last week in our Homerun Slides we started to talk about quality measures in patient care. Whenever we get information about this concept it always revolves around the practitioner, and how good a job we do, but often patient care is...


Letter from the Editor, #674

This week there is a new report out on the increased spending per year for diabetes care. This number is now well over 240 billion dollars, and when you add...


Editor's Note, DCMS #133

There is a lot of clamor about the new way of providing healthcare, and how quality becomes important to maximize reimbursement potential. A part of this quality initiative involves Value Based Purchasing. To help you understand the concept of VBP...


Letter from the Editor #673

If you have been a little behind on reading your emails you might not yet have seen the special edition that we sent out on the new SGLT2-Inhibitors now that the...


Editor's Note, DCMS #132

This week we continue our Clinical Text focus on macrovascular disease associated with diabetes. Dr. Beaser gets into a discussion as to which...


Letter from the Editor #672

This past week I was in the DC area talking to physicians about patient-centered Medical Homes and Accountable Care Organizations (ACO's). Much of the conversation revolved around Medicare and Medicaid plans and patients. As we were talking about...


Special Edition SGLT2 Letter from the Editor, Issue 1

This week we are pleased to bring you a special edition on the new SGLT2 Inhibitors. While many other publications have had information on this new class and the first of its kind approved drug, we decided to go into much more depth in our delivery...


Editor's Note, DCMS #131

Over the last seven weeks over 50% of the Diabetes Disasters Averted we have presented to you revolved around insulin errors. Our typical incident involves a medical professional finding an error just before it does severe harm to a patient....


Letter from the Editor #671

Our newly diagnosed patients receive so much information from friends, family, and the internet that they become desensitized to having diabetes and what that means in real terms. This overload of information and long list of do's and don'ts can be...


Editor's Note, DCMS #130

About three quarters of our diabetes patients have dyslipidemia and elevated triglycerides, along with high insulin resistance and an increased risk of CAD. Our Clinical Text from Joslin


Letter from the Editor #670

Last November our intern Andre McMahon put together a good article on How the Liver...


Editor's Note, DCMS #129

One of the most often mentioned and least understood acronyms in diabetes is HOMA. We see this four letter abbreviation used in almost every diabetes study and evaluation but exactly what is HOMA...


Letter from the Editor #669

Last week I asked all of you to contact your legislator about Senate Bill S1468 the Medicare Diabetes Self-Management Training Act of 2011 and the corresponding House of Representatives Bill HR2787. Not being one to ask you do do something that I...


Editor's Note, DCMS #128

We constantly talk to our diabetes patients about complications due to microvascular damage caused by elevated glucose levels. Nerve damage in the extremities and reduced kidney function are two we often speak about. However, only in recent...


Letter from the Editor #668:

This week we are sharing a plea from the American Association of Clinical Endocrinologists (AACE) for medical professionals and diabetes patients to urge members of Congress to pass the National Diabetes Clinical Care Commission Act. This...


Editor's Note, DCMS #127: Sick-day Rules for Diabetes Patients

It seems that every couple of weeks we are sharing new guidelines for treating problems related to diabetes, hypertension, hyperlipidemia, and the like. Often times we get a chart and a paragraph, and are left on our own to figure things out. When...


Letter from the Editor #667: Meaningful Use of EHRs Paying Less

Now that the sequestration has started, time alone will tell how much impact it will have on healthcare providers. We do know that according to CMS, Medicare incentive payments for meaningful use of electronic health records (EHRs)...


Editor's Note, DCMS #126

Have you ever heard of the "lag effect" (and I don't mean when you fall behind in a bike race)? This week our excerpt from Joslin's Diabetes Deskbook looks at


Letter from the Editor #666: ARK-Care Real-time Data Management System

It seems like every day there is a new study that conflicts with the results released only a couple of days before. Over the past 3 months we have had 5 articles discussing whether diet drinks increase caloric intake, appetite and diabetes risk.


Editor's Desk, #125: Special Feature Article from ISMP

Every week our readers share their stories of Diabetes Disasters Averted with us and most of the time these real-life experiences deal with insulin. There are many techniques and procedures that have been developed in order to help prevent...


Letter from the Editor, #665: Knowledge Gaps and Medical Professional

This week we have an article on the gaps in knowledge and information that prescribers have when it comes to diabetes care. In addition to these gaps...


Editor's Note, DCMS #124: Diabetes and Testosterone

Did you know that men with diabetes often have low free testosterone levels? If they are obese, this risk increases: about 50% of obese men with diabetes have low levels. Other factors influence levels also and in part two of our...


Letter from the Editor, #664: The Glucocard Expression

Every week our publisher and production editor give me a deadline to have my "Letter from the Editor" to them. It seems no matter how early I get started, I barely get it to them in time. This delay in doing my part causes all of us extra...


Editor's Note, DCMS # 123: Two New Insulins Delayed

Typically this clinical letter focuses on articles related to patient disasters averted, medical slides and clinical texts. However I am going to make an exception this week and share information from Novo Nordisk on the approval process for two...



Navigate through our listing of Letter From The Editor articles here.
First Previous Next Last

581 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
For your prediabetes patients who can't lower their blood glucose with lifestyle changes, do you prescribe GLP-1s or SGLT-2s?
CME/CE of the Week
Jeffrey A. Niezgoda, MD

Category: Wound Care
Credits: .75


Advertisement


Search Articles On Diabetes In Control